Skip to main content

Advertisement

SpringerLink
Log in

Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

These studies sought to determine the gene expression and short-term effects of intralesional lipid-complexed immunogene therapy with constructs encoding Staphylococcus aureus enterotoxin A and canine interleukin-2 (L-SEA/cIL-2) in dogs with tumors of various histotypes, and then to assess the safety and efficacy of repeated L-SEA/cIL-2 injections in dogs with spontaneous soft tissue sarcomas (STS). In the first study, pet dogs with a variety of tumors received a single intralesional injection of L-SEA/cIL-2, and surgical excision was performed 48 h later. In the second study, dogs with histologically confirmed STS were treated weekly for a maximum of 12 weeks with escalating doses of L-SEA/cIL-2. Tumors were then surgically excised and assessed histologically and immunohistochemically. Overall, treatments were well tolerated, with no dose-limiting toxicities encountered. At 48 h, in the single injection study, plasmid DNA was detected in 14 of 16 tumor samples, and plasmid-specific mRNA was detected in 3 of 14. In the multiple injection study, the overall response rate in dogs with STS was 25%, consisting of 3 complete responses (CR) and 1 partial response (PR). Diffuse lymphoplasmacytic inflammation was observed in all tumors from patients experiencing CR or PR, whereas these changes were not evident in tumors from nonresponders. The infiltrate was composed primarily of CD3+ cells at 48 h from the single-injection study, and was composed of both CD3+ and CD79a+ cells at 12 weeks in responding dogs from the multiple-injection study. In conclusion, these studies suggests that intralesional L-SEA/cIL-2 immunotherapy is well tolerated, results in detectable transgene expression in canine tumors, and has antitumor activity in dogs with spontaneous STS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2A, B.
Fig. 3A–D.

Similar content being viewed by others

References

  1. Silagi S, Dutkowski R, Schaefer A (1988) Eradication of mouse melanoma by combined treatment with recombinant human interleukin-2 and recombinant murine interferon-gamma. Int J Cancer 41:315

    Google Scholar 

  2. Yeung RS, Vollmer C, Taylor DD, Palazzo J, Weese JL (1992) Intratumoral rIL-2 based immunotherapy in B16 melanoma. J Surg Res 53:203

    CAS  PubMed  Google Scholar 

  3. Den Otter W, Hill FWG, Klein WR, Koten JW, Sterenberg PA, De Mulder PHM, Rhode C, Stewart R, Faber JAJ, Ruitenberg EJ, Rutten VPMG (1995) Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up. Cancer Immunol Immunother 41:10

    PubMed  Google Scholar 

  4. DeStefani A, Valente G, Forni G, Lerda W, Ragona R, Cortesina G (1996) Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations. J Immunother 19:125

    CAS  Google Scholar 

  5. Farkkila M, Jaaskelainen J, Kallio M, Blomstedt G, Raininko R, Virkkunen P, Pateau A, Sarelin H, Mantyla M (1994) Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma. Br J Cancer 70:138

    CAS  PubMed  Google Scholar 

  6. Mattijssen V, De Mulder PH, De Graeff A, Hupperets PS, Joosten F, Ruiter DJ, Bier H, Palmer PA, Van den Broek P (1994) Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma. Ann Oncol 5:957

    CAS  PubMed  Google Scholar 

  7. Forni G, Giovarelli M, Cavallo E, Consalvo M, Allione A, Modesti A, Muisani P, Colombo MP (1993) Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy. J Immunother 14:253

    CAS  PubMed  Google Scholar 

  8. Dow SW, Fradkin LG, Liggitt DH, Willson AP, Heath TD, Potter TA (1999) Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol 163:1552

    CAS  PubMed  Google Scholar 

  9. Fox BA, Drury M, Hu HM, Cao Z, Huntzicker EG, Qie W, Urba WJ (1998) Lipofection indirectly increases expression of endogenous major histocompatibility complex class I molecules on tumor cells. Cancer Gene Ther 5:307

    CAS  PubMed  Google Scholar 

  10. Hofland H, Huang L (1995) Inhibition of human ovarian carcinoma cell proliferation by liposome-plasmid DNA complex. Biochem Biophys Res Commun 207:492

    Article  CAS  PubMed  Google Scholar 

  11. Galanis E, Hersh EM, Stopeck AT, Gonzalez R, Burch P, Spier C, Akporiaye ET, Rinehart JJ, Edmonson J, Sobol RE, Forscher C, Sondak VK, Lewis BD, Unger EC, O'Driscoll M, Selk L, Rubin J (1999) Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. J Clin Oncol 17:3313

    CAS  PubMed  Google Scholar 

  12. Stopeck AT, Hersh EM, Akporiaye ET, Harris DT, Grogan T, Unger E, Warneke J, Schluter SF, Stahl S (1997) Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J Clin Oncol 15:341

    CAS  PubMed  Google Scholar 

  13. Stopeck, A.T, Jones A, Hersh EM, Thompson JA, Finucane DM, Gutheil JC, Gonzalez R (2001) Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/Beta-2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin Cancer Res 7:2285

    CAS  PubMed  Google Scholar 

  14. Daniels GA, Galanis E (2001) Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2 cDNA/DMRIE/DOPE lipid complex. Curr Opin Mol Ther 3:70

    CAS  PubMed  Google Scholar 

  15. Gleich LL, Gluckman JL, Nemunaitis J, Suen JY, Hanna E, Wolf GT, Coltrera MD, Villaret DB, Wagman L, Castro D, Gapany M, Carroll W, Gillespie D, Selk LM (2001) Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127:775

    CAS  PubMed  Google Scholar 

  16. Belldegrun A, Tso CL, Zisman A, Naitoh J, Said J, Pantuck AJ, Hinkel A, deKernion J, Figlin R (2001) Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology. Hum Gene Ther 12:883

    CAS  PubMed  Google Scholar 

  17. Lando PA, Hedlund G, Dohlsten M, Kalland T (1991) Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by Staphylococcal enterotoxin A. Cancer Immunol Immunother 33:231

    CAS  PubMed  Google Scholar 

  18. Micusan VV, Thibodeau J (1993) Superantigens of microbial origin. Sem Immunol 5:3

    Article  CAS  Google Scholar 

  19. Sriskandan S, Evans TJ, Cohen J (1996) Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma. J Immunol 156:2430

    CAS  PubMed  Google Scholar 

  20. McCormack JE, Callahan JE, Kappler J, Marrack PC (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785

    CAS  PubMed  Google Scholar 

  21. Dow SW, Potter TA (1997) Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses. J Clin Invest 99:2616

    CAS  PubMed  Google Scholar 

  22. Shrayer DP, Kouttab N, Hearing VJ, Wanebo HJ (1998) Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A. Cancer immunol Immunother 46:7

    CAS  PubMed  Google Scholar 

  23. Tordsson JM, Ohlsson LG, Abrahmsen LB, Karlstrom PJ, Lando PA, Brodin TN (2000) Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma. Cancer Immunol Immunother 48:691

    Article  CAS  PubMed  Google Scholar 

  24. Dow SW, Elmslie RE, Wilson AP, L R, Gorman C, Potter TA (1998) In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406

    CAS  PubMed  Google Scholar 

  25. Vail DM, MacEwen EG (2000) Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18:781

    CAS  PubMed  Google Scholar 

  26. Kuntz C, Dernell W, Powers BE, Devitt C, Straw RC, Withrow SJ (1997) Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 211:1147

    CAS  PubMed  Google Scholar 

  27. Nomura T, Nakajima S, Kawabata K, Yamashita F, Takakura Y, Hashida M (1997) Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res 57:2681

    CAS  PubMed  Google Scholar 

  28. Brehm D, Steinberg HM, Haviland J, Van Winkle T (1995) A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am An Hosp Assoc 31:349

    CAS  Google Scholar 

  29. Graves G, Bjorling D, Mahaffey E (1988) Canine hemangiopericytoma: 23 cases (1967–1984). J Am Vet Med Assoc 192:99

    CAS  PubMed  Google Scholar 

  30. Postorino N, Berg R, Powers BE, McChesney A, Taylor R, Withrow SJ (1988) Prognostic factors for canine hemangiopericytoma: 50 cases (1979–1984). J Am An Hosp Assoc 24:501

    Google Scholar 

Download references

Acnowledgements

The authors would like to dedicate this manuscript to their esteemed colleague and coauthor, the late Dr. E. Gregory MacEwen. They would also like to acknowledge the expert technical assistance of Lynda Beaver, Jean Tullis, and Robin Serino.

Author information

Authors and Affiliations

  1. Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive West, Madison, WI 53706, USA

    Douglas H. Thamm, Ilene D. Kurzman & E. Gregory Macewen

  2. The Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI 53706, USA

    E. Gregory Macewen

  3. Veterinary Medical Referral Service, Riverwoods, Illinois, USA

    Rhonda Feinmehl

  4. Heska Corporation, Fort Collins, Colorado, USA

    Todd L. Towell, Susan L. Longhofer, Christine M. Johnson, Frank J. Geoly & Dan T. Stinchcomb

Authors
  1. Douglas H. Thamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilene D. Kurzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Gregory Macewen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rhonda Feinmehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Todd L. Towell
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susan L. Longhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christine M. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Frank J. Geoly
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dan T. Stinchcomb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas H. Thamm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thamm, D.H., Kurzman, I.D., Macewen, E.G. et al. Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors. Cancer Immunol Immunother 52, 473–480 (2003). https://doi.org/10.1007/s00262-003-0387-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-003-0387-6

Keywords

Search

Navigation